Because ZST enables us to offer a Living Technology, we are able to continue to provide these significant upgrades to help keep our customers at the cutting-edge of ultrasound
Chicago, IL (PRWEB) November 28, 2016
Mindray/ZONARE, developer of next generation ultrasound technology, announced a major upgrade for the company’s ZS3 ultrasound platform at the annual Radiology Society of North America (RSNA) congress being held in Chicago, IL, November 27 – December 2, 2016. The new upgrade provides several enhancements including a significant contrast enhanced ultrasound (CEUS) and image optimization advancement using a recently developed digital synthetic spatial compounding (DSSC) element.
“Using our patented ZONE Sonography Technology (ZST), we are able to create spatially compounded B-mode images using acoustic data from a single transmitted wave compared with conventional compounding methods which require multiple transmissions. We believe this is unprecedented in the industry,” said Glen McLaughlin, PhD, chief product officer, Mindray. “DSSC is especially useful with CEUS imaging as we are able to interrogate the region of interest with just one acoustic wavefront, which is designed to significantly reduce the destruction of micro-bubbles. The system’s software then rapidly processes the received echo information, resulting in enhanced image clarity due to greater retention of micro-bubble volume.”
As DSSC breaches the temporal constraints of conventional spatial compounding, B-mode image quality and frame rate are virtually unaffected when employing multiple imaging modalities. DSSC is enabled for B-mode across the entire family of ZST platform transducers. The new enhancement is available to all ZS3 system customers as part of the 5-year state-of-the-art guarantee, which was provided from the date of initial purchase of the unit.
“Because ZST enables us to offer a Living Technology, we are able to continue to provide these significant upgrades to help keep our customers at the cutting-edge of ultrasound,” said McLaughlin. “We believe in partnering with our customers beyond just selling a box that becomes obsolete in a few months. Due to this mission, we have enjoyed many long and ongoing years with a wide variety of healthcare providers.”
The release also provides additional image quality improvements, needle optimization for the L8-3 and L10-5 transducers, plus significant new calculation enhancements including a new package for small parts. A purchasable 3D/4D mode is available as well as is Qview, which interacts with a Qpath server for maximizing workflow.
Mindray is a leading developer, manufacturer and marketer of medical devices worldwide. Mindray maintains its global headquarters in Shenzhen, China; North American headquarters in Mahwah, New Jersey; and multiple development facilities and offices in major international markets including an ultrasound Innovation Center in Silicon Valley, CA. Mindray supplies a broad range of products across three primary business segments, patient monitoring and life support, in-vitro diagnostics, and medical imaging systems. For more information, please visit http://www.mindray.com.
ZONARE is a wholly owned subsidiary of Mindray located in Silicon Valley, CA. As a Mindray Center of Innovation, the company is solely dedicated to ultrasound excellence through its innovative, award-winning next generation technology which provides the platform for the company’s Living Technology designed to meet its customers evolving imaging needs. The patented design and ZONE Sonography® Technology (ZST) architecture of the Z.One PRO and ZS3 platforms deliver high-end image quality and clinical versatility.
# # #